https://www.fresenius.com en-us Wed, 16 Sep 2026 15:44:55 +0200 Wed, 16 Sep 2026 15:44:55 +0200 Wed, 16 Sep 2026 15:44:55 +0200 <![CDATA[DRG inflator 2027 expected at 4.85%]]> Wed, 09 Sep 2026 19:31:49 +0200 <![CDATA[Fresenius reorganizes its hospital services business]]> Mon, 07 Sep 2026 12:45:00 +0200 <![CDATA[Fresenius expands Medical Nutrition Portfolio with new real-food-based enteral nutrition concept]]> Fri, 21 Aug 2026 00:00:00 +0200 <![CDATA[Fresenius raises approximately €300 million through sale of 7.8 million Fresenius Medical Care shares]]> Mon, 10 Aug 2026 19:34:21 +0200 <![CDATA[Fitch Ratings upgrades outlook for Fresenius SE from stable to positive]]> Thu, 06 Aug 2026 19:00:00 +0200 <![CDATA[Fresenius transitions to registered shares – automatic conversion for shareholders]]> Wed, 05 Aug 2026 04:01:00 +0200 <![CDATA[#FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised]]> Mon, 03 Aug 2026 14:30:00 +0200 <![CDATA[Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market]]> Fri, 31 Jul 2026 14:19:54 +0200 <![CDATA[Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate]]> Thu, 23 Jul 2026 16:00:00 +0200 <![CDATA[Fresenius establishes venture fund of more than €200 million to drive healthcare innovation]]> Wed, 15 Jul 2026 16:14:29 +0200 <![CDATA[Q2 2026 Aide Memoire available]]> financial results section.As a service to capital market participants, Fresenius provides a quarterly Aide Memoire ahead of the publication of the Company's quarterly results. This document includes a summary of relevant information that Fresenius has communicated previously or made publicly available to the capital market or otherwise. Fresenius' Q2 2026 financial results will be published on August 5, 2026.]]> Mon, 13 Jul 2026 13:00:00 +0200 <![CDATA[GKV Stabilization Act approved]]> Thu, 02 Jul 2026 00:20:00 +0200 <![CDATA[Fresenius successfully issues €1 billion in bonds]]> Mon, 08 Jun 2026 22:02:32 +0200 <![CDATA[Fresenius announces European launch of Pedismof® range]]> Tue, 02 Jun 2026 15:00:00 +0200 <![CDATA[Fresenius Opens Innovation Center for Medical Nutrition in Bad Homburg]]> Tue, 26 May 2026 20:00:00 +0200 <![CDATA[AI assistant enhances access to Investor Relations information]]> https://www.fresenius.com/AskFRE-Your-IR-Assistant ]]> Wed, 06 May 2026 12:45:00 +0200 <![CDATA[#FutureFresenius: REJUVENATE in action – Excellent start to the year - demonstrating continued strength and resilient performance; Guidance reconfirmed]]> Fri, 17 Apr 2026 15:32:26 +0200 <![CDATA[Q1 2026 Aide Memoire available]]> Investor Relations website.As a service to capital market participants, Fresenius provides a quarterly Aide Memoire ahead of the publication of the Company's quarterly results. This document includes a summary of relevant information that Fresenius has communicated previously or made publicly available to the capital market or otherwise. Fresenius' Q1 2026 financial results will be published on May 6, 2026.]]> Wed, 08 Apr 2026 17:58:59 +0200 <![CDATA[#FutureFresenius is paying off: S&P Global Ratings revises outlook for Fresenius SE from stable to positive]]> Wed, 25 Mar 2026 21:00:00 +0100 <![CDATA[Fresenius publishes 2025 Annual Report – REJUVENATE: Delivering accelerated performance for long-term value creation]]>